AnaptysBio (ANAB)
(Real Time Quote from BATS)
$22.48 USD
+1.18 (5.54%)
Updated Apr 30, 2024 10:16 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -1.54 |
EPS Last Quarter | -1.59 |
Last EPS Surprise | 8.62% |
ABR | 1.55 |
Earnings ESP
|
8.36% |
---|---|
Current Year | -6.17 |
Next Year | -5.94 |
EPS (TTM) | -6.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.55M | 5.22M | 21.93M | 31.31M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 7.00M | 9.00M | 37.00M | 54.00M |
Low Estimate | 3.00M | 3.00M | 12.00M | 12.00M |
Year ago Sales | 1.37M | 3.46M | 17.16M | 21.93M |
Year over Year Growth Est. | 232.12% | 50.78% | 27.80% | 42.79% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.54 | -1.54 | -6.17 | -5.94 |
# of Estimates | 7 | 6 | 7 | 6 |
Most Recent Consensus | -1.41 | -1.44 | -5.71 | -6.37 |
High Estimate | -1.41 | -1.43 | -5.68 | -4.45 |
Low Estimate | -1.90 | -1.87 | -6.95 | -7.50 |
Year ago EPS | -1.58 | -1.50 | -6.08 | -6.17 |
Year over Year Growth Est. | 2.53% | -2.67% | -1.48% | 3.77% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.54 | -1.54 | -6.17 | -5.94 |
7 Days Ago | -1.54 | -1.54 | -6.17 | -5.94 |
30 Days Ago | -1.56 | -1.56 | -6.25 | -5.86 |
60 Days Ago | -1.57 | -1.61 | -6.46 | -6.24 |
90 Days Ago | -1.57 | -1.58 | -6.38 | -6.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.41 | -1.44 | -5.71 | -6.37 |
Zacks Consensus Estimate | -1.54 | -1.54 | -6.17 | -5.94 |
Earnings ESP | 8.36% | 6.60% | 7.52% | -7.21% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.59 | -1.41 | -1.50 | -1.58 | NA |
Estimate | -1.74 | -1.72 | -1.65 | -1.04 | NA |
Difference | 0.15 | 0.31 | 0.15 | -0.54 | 0.02 |
Surprise | 8.62% | 18.02% | 9.09% | -51.92% | -4.05% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more